coronary artery disease
Variants at three of these loci have previously been linked with important clinical outcomes: SLC7A9 is a risk locus for chronic kidney disease, NAT2 for coronary artery disease and genotype-dependent response to drug toxicity, and SLC6A20 for iminoglycinuria.
Variants at three of these loci have previously been linked with important clinical outcomes: SLC7A9 is a risk locus for chronic kidney disease, <span class="gene" id="21572414-5-145-149">NAT2</span> for <span class="disease" id="21572414-5-154-177">coronary artery disease</span> and genotype-dependent response to drug toxicity, and SLC6A20 for iminoglycinuria.